Preparation, writing and redaction of clinical study reports
BlueReg can support in preparing and writing clinical study reports
Providing the redaction proposal document package for submission to the European Medicines Agency (EMA); anonymizing individual patient data (IPD) and redacting commercially confidential information (CCI) to comply with EMA policy 0070 on the publication of clinical data for medicinal products for human use.
Our experts
Our team can also support you through the entire application process from development, to registration and post-approval management
Associated News